This PDF 1.5 document has been generated by PScript5.dll Version 5.2.2 / Acrobat Distiller 11.0 (Windows), and has been sent on pdf-archive.com on 18/06/2018 at 13:19, from IP address 92.253.x.x.
The current document download page has been viewed 313 times.
File size: 585.24 KB (2 pages).
Privacy: public file
Sponsors
Target audience
The meeting is aimed at pathologists-in-training, molecular biologists,
and medical and surgical oncologists and surgeons.
Under the auspices of
PATHOLOGY MEETING
ADVANCES IN
PATHOLOGY
AND
MOLECULAR DIAGNOSTICS
in the E
Era of Personalized Cancer Therap
py
Accreditation
Continuing Education Credits requested to the Spanish National Health System
With the collaboration of the Educational Committee of the MD Anderson Cancer Center Madrid
Certification
Madriid, October 5-7, 2016
Meeting Directors
Dr. Joseph Khoury
Dr. Juan Fernando García García
Venue
Mutua Madrileña Auditorium
Paseo de la Castellana, 33.
Madrid, Spain
Meeting secretariat
Monasterios de Suso y Yuso 34, 4-14-2, 28049 Madrid, Spain
Tel.: +34 91 372 0203 · E-mail: pathologymeeting@doctaforum.com
Registrations: www.mdanderson.es/pathologymeeting
@MDAnderson_ES
Wednesday, October 5th, 2016
11:45 - 13:30 Session 4: Breast cancer
Moderator:
13:00 - 14:00 Registration
Friday, October 7th, 2016
Dr. W. Frayser Symmans, The University of Texas MD Anderson Cancer Center. Houston, USA
11:45 - 12:15 Genomic prediction and breast cancer
08:30 - 09:30 Plenary lecture
Dr. W. Frayser Symmans, The University ofTexas MD Anderson Cancer Center. Houston, USA
14:00 - 14:15 Welcome / Overview
Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain
Moderator:
Dr. Víctor Prieto, The University of Texas MD Anderson Cancer Center. Houston, USA
14:15 - 15:00 Aggressive tumors of the skin appendages: Merkel cell carcinoma and other new entities
Dr. Víctor Prieto, The University of Texas MD Anderson Cancer Center. Houston, USA
15:00 - 15:45 Utility of molecular pathology techniques in the diagnosis of melanoma
Dr. José Luis Rodríguez-Peralto, Hospital Universitario 12 de Octubre. Madrid, Spain
15:45 - 16:00 Discussion
16:00 - 16:30 Coffee break
16:30 - 17:15 Inaugural lecture
Personalized cancer therapy and the future of health care
12:45 - 13:15 Therapeutic impact of molecular pathology in breast cancer: A clinical point of view
17:15 - 19:00 Session 2: Lung tumors
Moderator:
Dr. Ignacio Wistuba, The University of Texas MD Anderson Cancer Center. Houston, USA
17:15 - 18:00 Molecular pathology of lung cancer - 2016
Dr. Ignacio Wistuba, The University of Texas MD Anderson Cancer Center. Houston, USA
18:00 - 18:45 Application in Spain of the latest advances in lung cancer
Dr. Pilar López-Criado, MD Anderson Cancer Center Madrid, Spain
18:45 - 19:00 Discussion
Personalized cancer therapy: Can you MATCH this?
14:30 - 16:15 Session 5: Gynecologic tumors
10:15 - 10:45 What’s new in T-cell lymphomas and Hodgkin lymphoma
Moderator:
09:30 - 10:15 Diffuse large B-cell lymphoma
Dr. L. Jeffrey Medeiros, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain
Dr. Anais Malpica, The University of Texas MD Anderson Cancer Center. Houston, USA
14:30 - 15:00 Ovarian cancer, from molecular pathology to the 2014 WHO classification:
What you need to know
Dr. Anais Malpica, The University of Texas MD Anderson Cancer Center. Houston, USA
15:00 - 15:30 Integrating molecular pathology in histological typing and prediction of
recurrence in endometrial carcinoma
Dr. Xavier Matías-Guiu, Hospital Universitari Arnau de Vilanova. Lleida, Spain.
Hospital Universitari de Bellvitge. Barcelona, Spain
15:30 - 16:00 Deciphering intratumoral molecular heterogeneity in gynecological cancer
Dr. Gema Moreno-Bueno, MD Anderson Cancer Center Madrid, Spain
10:45 - 11:15 New insights into myeloid neoplasms
Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA
10:15 - 11:30 Discussion
11:30 - 12:00 Coffee break
12:00 - 13:45 Session 9: Genitourinary tumors
Moderator:
Dr. Kanishka Sircar, The University of Texas MD Anderson Cancer Center. Houston, USA
12:45 - 13:30 The evolving landscape of urothelial bladder cancer
Dr. Francisco X. Real, Spanish National Cancer Research Center (CNIO). Madrid, Spain
16:15 - 18:00 Session 6: Sarcoma
Moderator:
Dr. Gemma Toledo Santana, MD Anderson Cancer Center Madrid, Spain
16:15 - 17:00 From genomics to practical clinical molecular diagnostics in sarcoma:
Where do we stand?
Dr. Alexander Lazar, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Enrique de Álava Casado, Hospital Virgen del Rocío. Seville, Spain
17:45 - 18:00 Discussion
18:00 - 18:30 Coffee break
13:30 - 13:45 Discussion
13:45 - 15:15 Lunch
15:15 - 17:00 Session 10: Central nervous system tumors
Moderator:
Dr. Stanley R. Hamilton, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Gregory N. Fuller, The University of Texas MD Anderson Cancer Center. Houston, USA
16:00 - 16:45 Molecular genetics of gliomas
Moderator:
18:30 – 19:00
19:00 – 19:20
10:15 - 11:00 Molecular pathology of gastric cancer
Dr. Fátima Carneiro, Centro Hospitalar de São João. Porto, Portugal
11:00 - 11:15 Discussion
11:15 - 11:45 Coffee break
Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain
FISH in diagnostic pathology: current applications and automatization
Dra. Blanca Espinet, Hospital del Mar. Barcelona, Spain
09:30 - 10:15 Tumor microenvironment and pancreatic cancer progression
Dr. Huamin Wang, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain
15:15 - 16:00 Molecular classification of brain tumors comes of age: Introducing the 2016 World
Health Organization classification of tumors of the central nervous system
Dr. Bárbara Meléndez Asensio, Hospital Virgen de la Salud.Toledo, Spain
18:30 - 20:00 Session 7: Platform presentations
Moderator:
Dr. Kanishka Sircar, The University of Texas MD Anderson Cancer Center. Houston, USA
12:00 - 12:45 Renal cell carcinoma: A morphologic and molecular understanding of
aggressive and indolent tumors
16:00 - 16:15 Discussion
Dr. Stanley R. Hamilton, The University of Texas MD Anderson Cancer Center. Houston, USA
09:30 - 11:15 Session 3: Gastrointestinal tumors
Dr. L. Jeffrey Medeiros, The University of Texas MD Anderson Cancer Center. Houston, USA
Moderator:
17:00 - 17:45 Molecular diagnostics and real life in sarcoma signout
Thursday, October 6th, 2016
08:30 - 09:30 Keynote lecture
09:30 - 11:30 Session 8: Hematolymphoid tumors
13:15 - 13:30 Discussion
13:30 - 14:30 Lunch
Dr. Joxel García, Executive Director, Cancer Control Platform, Moon Shots Operations.
The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Miguel Ángel Piris Pinilla, Hospital Universitario Marqués de Valdecilla. Santander, Spain
Dr. José Palacios Calvo, Hospital Universitario Ramón y Cajal. Madrid, Spain
Dr. Antonio González-Martín, MD Anderson Cancer Center Madrid, Spain
14:15 - 16:00 Session 1: Skin tumors
Lymphoproliferative diagnosis: integrated diagnosis paves the way to
precision medicine
12:15 - 12:45 New insights into the molecular pathology of lobular breast carcinoma
MEK and PIK3CB inhibitor combination as a promising therapeutical
approach for sarcomatoid mesothelioma
Dra. Miriam Marqués, Spanish National Cancer Research Center (CNIO). Madrid, Spain
19:20 – 19:40
Cancer of unknown primary origin in a patient with a presacral mass
and nerve sheath involvement
Dra. Tamara Ranchal, MD Anderson Cancer Center. Madrid, Spain
19:40 – 20:00
Circadian regulation of cancer stem cell markers in colorectal tumors
Dra. Inés Aroca, Instituto de Investigación Biosanitaria de Granada. Granada, Spain
16:45 - 17:00 Discussion
17:00 - 17:30 Coffee break
17:30 - 19:00 Session 11: Platform presentations
Moderator:
Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA
Case presentations / Platform presentations
19:00 - 19:30 Closing remarks
Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center. Houston, USA
Dr. Juan Fernando García García, MD Anderson Cancer Center Madrid, Spain
2534 - MD Anderson Cancer Center Madrid- Pathology Meeting - program.pdf (PDF, 585.24 KB)
Use the permanent link to the download page to share your document on Facebook, Twitter, LinkedIn, or directly with a contact by e-Mail, Messenger, Whatsapp, Line..
Use the short link to share your document on Twitter or by text message (SMS)
Copy the following HTML code to share your document on a Website or Blog